THE E47 TRANSCRIPTION FACTOR BINDS TO THE ENHANCER SEQUENCES OF RECOMBINANT MURINE LEUKEMIA VIRUSES AND INFLUENCES ENHANCER FUNCTION

Citation
Sc. Lawrenzsmith et Cy. Thomas, THE E47 TRANSCRIPTION FACTOR BINDS TO THE ENHANCER SEQUENCES OF RECOMBINANT MURINE LEUKEMIA VIRUSES AND INFLUENCES ENHANCER FUNCTION, Journal of virology, 69(7), 1995, pp. 4142-4148
Citations number
63
Categorie Soggetti
Virology
Journal title
ISSN journal
0022538X
Volume
69
Issue
7
Year of publication
1995
Pages
4142 - 4148
Database
ISI
SICI code
0022-538X(1995)69:7<4142:TETFBT>2.0.ZU;2-A
Abstract
The genomes of most recombinant murine leukemia viruses (MuLVs) inheri t pathogenic U3 region sequences from the endogenous xenotropic provir us Bxv-1. However, the U3 regions of about one-third of recombinant Mu LVs from CWD mice, such as CWM-T15, have nonecotropic substitutions th at are probably derived from an endogenous polytropic provirus. The CW M-T15 U3 region sequences contain five nucleotide substitutions compar ed with the less pathogenic sequences of the endogenous ecotropic viru s parent, Emv-1. Three of these substitutions are located immediately 3' of the enhancer core, and two form part of an E-box motif that is a lso found in the Bxv-2 sequence. A series of electromobility shift ass ays revealed that nuclear extracts from S194 cells and the basic helix -loop-helix transcription factor E47 could distinguish between oligonu cleotides that contained the core region sequences of CWM-T15 or Emv-1 . The E47 homodimers appeared to bind to the CWM-T15 E box motif and w hen expressed at high levels in cells transactivated the CWM-T15 but n ot the Emv-1 enhancer. Taken together, these results suggest that E47 or related basic helix-loop-helix proteins that are expressed in lymph oid cells bind to and transactivate the CWM-T15 enhancer in vivo. This transactivation may explain why the CWM-T15 and Bxv-1 U3 regions acce lerate the onset of lymphoid neoplasms and why related enhancer core r egion sequences are preferentially incorporated into the genomes of re combinant MuLVs and are found in other leukemogenic mammalian retrovir uses.